Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lekhim-Kharkiv is a leading Ukrainian pharmaceutical company and a core manufacturing subsidiary of the Lekhim Group. Founded in 1995 and headquartered in Kharkiv, the company operates a large-scale, GMP-certified production facility dedicated to finished dosage forms. Its extensive product portfolio includes over 100 generic medications, ranging from essential antibiotics and cardiovascular drugs to specialized suppositories and injectable solutions. Lekhim-Kharkiv is recognized for its significant contribution to the Ukrainian healthcare market and its strategic international partnerships, including a high-profile collaboration with Sinovac Biotech for vaccine supply and localized production. The company continues to maintain operations as a critical supplier of medicines within the region despite the challenges posed by the ongoing conflict.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lekhim-Kharkiv.